Emergent Biosolutions (EBS +4%) gains this morning after announcing that its experimental drug TRU-016, a potential treatment for chronic lymphocytic leukemia, was designated as an orphan medicinal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback